The jury yesterday found that Walter Lian-Heen Liew, his company, USA Performance Technology Inc. (USAPTI), and Robert Maegerle conspired to steal trade secrets from E.I. DuPont de Nemours & Company regarding their chloride-route titanium dioxide production technology and sold those secrets for large sums of money to state-owned Chinese companies.
The purpose of their conspiracy was to help those companies develop large-scale chloride-route titanium dioxide production capability in the China, including a planned 100,000-ton titanium dioxide factory in Chongqing, the Justice Department said in a statement.
"The theft of America's trade secrets for the benefit of a foreign government poses a substantial threat to our economic and national security" said Acting Assistant Attorney General John Carlin.
In a statement, the Justice Department said evidence at trial showed that in the 1990s, Liew met with the government of China and was informed that China had prioritised the development of chloride-route titanium dioxide (TiO2) technology.
DuPont's TiO2 chloride-route process also produces titanium tetrachloride, a material with military and aerospace uses.
"Liew executed contracts with state-owned entities in China for chloride-route TiO2 projects that relied on the transfer of illegally obtained DuPont technology.
Liew, Maegerle, and USAPTI obtained and sold DuPont's TiO2 trade secret to the Pangang Group companies for more than USD 20 million," the statement said.
Tze Chao, a former DuPont employee who was also charged in the second superseding indictment, pleaded guilty to conspiracy to commit economic espionage on March 1, 2012.
He is currently a fugitive.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
